Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gemcitabine Cisplatin and Durvalumab Experience in Advanced Biliary Tract Cancers: A Real-World, Multicentric Data From India.
Muddu VK, Shah A, John A, Raj A, Bahl A, Rajappa SJ, Raja T, Ghosh J, Lavingia V, Vora A, Bhargava P, Ramaswamy A, Khan A, Sharma A, Trikha M, Dhanawat A, Bonda A, Siripurapu I, Mahajan M, Rohatgi N, Chandrakant MV, Gujarathi H, Vora M, Ankathi S, Ostwal VS. Muddu VK, et al. Among authors: dhanawat a. JCO Glob Oncol. 2024 Dec;10:e2400216. doi: 10.1200/GO.24.00216. Epub 2024 Dec 5. JCO Glob Oncol. 2024. PMID: 39637344
Performance of Low-Dose Immunotherapy and Standard-Dose Immunotherapy in Microsatellite Instability-High Metastatic Colorectal Cancer: Real-World Data (CLouD-High Study).
Trikha M, Sarkar L, Dhanawat A, Syed N, Gujarathi H, Vora M, Sivakumar Raja AS, Bhargava P, Ramaswamy A, Mandavkar S, Saklani A, Kaushal RK, Bal M, Shetty O, Yadav S, Ostwal V. Trikha M, et al. Among authors: dhanawat a. JCO Glob Oncol. 2024 Aug;10:e2400141. doi: 10.1200/GO.24.00141. JCO Glob Oncol. 2024. PMID: 39159410
Olanzapine as Antiemetic Prophylaxis in Moderately Emetogenic Chemotherapy: A Phase 3 Randomized Clinical Trial.
Ostwal V, Ramaswamy A, Mandavkar S, Bhargava P, Naughane D, Sunn SF, Srinivas S, Kapoor A, Mishra BK, Gupta A, Sansar B, Pal V, Pandey A, Bonda A, Siripurapu I, Muddu VK, Kannan S, Chaugule D, Patil R, Parulekar M, Dhanawat A, Trikha M, Ghosh J, Noronha V, Menon N, Patil V, Prabhash K, Olver I. Ostwal V, et al. Among authors: dhanawat a. JAMA Netw Open. 2024 Aug 1;7(8):e2426076. doi: 10.1001/jamanetworkopen.2024.26076. JAMA Netw Open. 2024. PMID: 39106066 Free PMC article. Clinical Trial.
A Comparative Study Evaluating the Quality of Life and Survival Outcomes in Patients Receiving Chemotherapy Versus Oral Tyrosine Kinase Inhibitor in the Third Line and Beyond Setting for Advanced NSCLC.
Noronha V, Menon NS, Patil VM, Chandrakanth MV, More S, Dhanawat A, Chowdhary OR, Singh AC, Goud S, Shah S, Karuvandan N, Jobanputra KN, Shah DK, Shah MJ, Sarma R, Patel D, Joarder R, Kumar P, John A, Kaur J, Bagra S, Purandare N, Janu A, Mahajan A, Prabhash K. Noronha V, et al. Among authors: dhanawat a. JTO Clin Res Rep. 2023 Dec 18;5(1):100622. doi: 10.1016/j.jtocrr.2023.100622. eCollection 2024 Jan. JTO Clin Res Rep. 2023. PMID: 38292414 Free PMC article.
Long-term outcomes of neo-adjuvant chemotherapy on borderline resectable oral cavity cancers: Real-world data of 3266 patients and implications for clinical practice.
Noronha V, Dhanawat A, Patil VM, Menon N, Singh AK, Chaturvedi P, Pai P, Chaukar D, Laskar SG, Prabhash K. Noronha V, et al. Among authors: dhanawat a. Oral Oncol. 2024 Jan;148:106633. doi: 10.1016/j.oraloncology.2023.106633. Epub 2023 Nov 21. Oral Oncol. 2024. PMID: 37988838 Clinical Trial.
17 results